洁特生物
(688026)
| 流通市值：23.53亿 | | | 总市值：23.54亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 398,180,432.24 | 268,140,905.35 | 123,822,565.32 | 558,657,564.04 |
| 营业收入 | 398,180,432.24 | 268,140,905.35 | 123,822,565.32 | 558,657,564.04 |
| 二、营业总成本 | 340,567,157.86 | 220,599,611.29 | 102,556,702.56 | 455,656,819.11 |
| 营业成本 | 230,250,909.34 | 153,997,703.2 | 70,715,948.36 | 327,302,345.11 |
| 税金及附加 | 9,228,595.79 | 3,979,869.31 | 1,478,187.92 | 9,819,468.79 |
| 销售费用 | 25,741,151.77 | 16,074,445.66 | 8,081,163.65 | 34,340,415.88 |
| 管理费用 | 36,589,353.62 | 23,849,243.8 | 9,681,837.54 | 45,404,150.36 |
| 研发费用 | 21,096,099.18 | 13,311,672.7 | 5,846,178.82 | 26,250,379.03 |
| 财务费用 | 17,661,048.16 | 9,386,676.62 | 6,753,386.27 | 12,540,059.94 |
| 其中:利息费用 | 21,084,119.7 | 13,980,873.68 | 6,946,760.37 | 26,439,233.26 |
| 其中:利息收入 | 1,754,847.46 | 1,606,906.12 | 45,722.68 | 14,521,239.4 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 732,534.53 | - | - |
| 加:投资收益 | 1,921,204.37 | 1,112,409.37 | -271,416.77 | -1,002,041.49 |
| 资产处置收益 | -238,323.9 | - | - | -167,342.79 |
| 资产减值损失(新) | 283,825.69 | 438,825.26 | -3,660,442.3 | -10,707,009.15 |
| 信用减值损失(新) | 1,667,047.25 | 378,993.48 | 2,095,646.39 | -3,781,976.28 |
| 其他收益 | 4,668,644.59 | 3,060,799.59 | 1,346,494 | 8,392,539.63 |
| 四、营业利润 | 65,915,672.38 | 53,264,856.29 | 20,776,144.08 | 95,734,914.85 |
| 加:营业外收入 | 149,698.05 | 134,396.48 | 108,125.94 | 17,186.74 |
| 减:营业外支出 | 230,139.02 | 58,774.33 | - | 134,857.21 |
| 五、利润总额 | 65,835,231.41 | 53,340,478.44 | 20,884,270.02 | 95,617,244.38 |
| 减:所得税费用 | 7,209,481.87 | 5,760,366.87 | 3,558,825.06 | 22,654,698.94 |
| 六、净利润 | 58,625,749.54 | 47,580,111.57 | 17,325,444.96 | 72,962,545.44 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 58,625,749.54 | 47,580,111.57 | 17,325,444.96 | 72,962,545.44 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 57,291,336.8 | 46,338,648.8 | 16,462,336.91 | 72,189,560.75 |
| 少数股东损益 | 1,334,412.74 | 1,241,462.77 | 863,108.05 | 772,984.69 |
| 扣除非经常损益后的净利润 | 53,163,217.03 | 42,916,326.59 | 15,649,184.18 | 67,749,591.4 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.42 | 0.34 | 0.12 | 0.52 |
| (二)稀释每股收益 | 0.42 | 0.34 | 0.12 | 0.52 |
| 八、其他综合收益 | 95,203.13 | 147,760.46 | -56,023.58 | 640,565.68 |
| 归属于母公司股东的其他综合收益 | 95,203.13 | 147,760.46 | -56,023.58 | 640,565.68 |
| 九、综合收益总额 | 58,720,952.67 | 47,727,872.03 | 17,269,421.38 | 73,603,111.12 |
| 归属于母公司股东的综合收益总额 | 57,386,539.93 | 46,486,409.26 | 16,406,313.33 | 72,830,126.43 |
| 归属于少数股东的综合收益总额 | 1,334,412.74 | 1,241,462.77 | 863,108.05 | 772,984.69 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-26 | 2025-04-16 |
| 审计意见(境内) | | | | 标准无保留意见 |